These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15474280

  • 21. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.
    Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747
    [Abstract] [Full Text] [Related]

  • 22. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.
    Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345
    [Abstract] [Full Text] [Related]

  • 23. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
    Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 01; 7(6):531-6. PubMed ID: 9641498
    [Abstract] [Full Text] [Related]

  • 24. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.
    Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863
    [Abstract] [Full Text] [Related]

  • 25. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.
    Clin Cancer Res; 2005 Jun 01; 11(11):4037-43. PubMed ID: 15930338
    [Abstract] [Full Text] [Related]

  • 26. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 27. [Detection of DNA hypermethylation as a potential biomarker for prostate cancer].
    Tilandyová P, Kajo K, Kliment J, Plank L, Lasabová Z.
    Klin Onkol; 2010 Dec 15; 23(5):293-9. PubMed ID: 21061679
    [Abstract] [Full Text] [Related]

  • 28. Methylated genes as potential biomarkers in prostate cancer.
    Phé V, Cussenot O, Rouprêt M.
    BJU Int; 2010 May 15; 105(10):1364-70. PubMed ID: 20067451
    [Abstract] [Full Text] [Related]

  • 29. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 30. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS, Foley R, Woodson K, Lawler M.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):357-77. PubMed ID: 16728568
    [Abstract] [Full Text] [Related]

  • 31. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.
    Anal Biochem; 2009 Sep 15; 392(2):117-25. PubMed ID: 19505431
    [Abstract] [Full Text] [Related]

  • 32. DNA-based detection of prostate cancer in blood, urine, and ejaculates.
    Goessl C, Müller M, Heicappell R, Krause H, Miller K.
    Ann N Y Acad Sci; 2001 Sep 15; 945():51-8. PubMed ID: 11708494
    [Abstract] [Full Text] [Related]

  • 33. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
    Eilers T, Machtens S, Tezval H, Blaue C, Lichtinghagen R, Hagemann J, Jonas U, Serth J.
    Prostate; 2007 May 15; 67(7):757-63. PubMed ID: 17373715
    [Abstract] [Full Text] [Related]

  • 34. Silencing of pi-class glutathione S-transferase in MDA PCa 2a and MDA PCa 2b cells.
    Vidanes GM, Paton V, Wallen E, Peehl DM, Navone N, Brooks JD.
    Prostate; 2002 Jun 01; 51(4):225-30. PubMed ID: 11987150
    [Abstract] [Full Text] [Related]

  • 35. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.
    Urology; 2008 Jan 01; 71(1):161-7. PubMed ID: 18242387
    [Abstract] [Full Text] [Related]

  • 36. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R, Ribeiro FR, Fonseca D, Hoque MO, Carvalho AL, Costa VL, Pinto M, Oliveira J, Teixeira MR, Sidransky D, Jerónimo C.
    Clin Cancer Res; 2007 Oct 15; 13(20):6122-9. PubMed ID: 17947477
    [Abstract] [Full Text] [Related]

  • 37. Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.
    Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D.
    Clin Cancer Res; 2004 Aug 15; 10(16):5518-22. PubMed ID: 15328191
    [Abstract] [Full Text] [Related]

  • 38. The epigenetic promise for prostate cancer diagnosis.
    Van Neste L, Herman JG, Otto G, Bigley JW, Epstein JI, Van Criekinge W.
    Prostate; 2012 Aug 01; 72(11):1248-61. PubMed ID: 22161815
    [Abstract] [Full Text] [Related]

  • 39. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
    Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG, Merletti F.
    J Clin Oncol; 2009 Jul 01; 27(19):3161-8. PubMed ID: 19470943
    [Abstract] [Full Text] [Related]

  • 40. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.
    J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.